These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 22175513)
21. An interview with Thomas Levelli. Interview by Vicki Glaser. Levelli T Assay Drug Dev Technol; 2005 Feb; 3(1):1-6. PubMed ID: 15798390 [No Abstract] [Full Text] [Related]
22. [Created by knowledge]. Berg SF Tidsskr Nor Laegeforen; 2010 Dec; 130(24):2499-503. PubMed ID: 21164596 [No Abstract] [Full Text] [Related]
23. Then and now. Verma I Nature; 2005 Jul; 436(7050):478-9. PubMed ID: 16049468 [No Abstract] [Full Text] [Related]
24. Interview with Ray Kurzweil. Interview by Vicki Glaser. Kurzweil R Rejuvenation Res; 2011 Oct; 14(5):567-72. PubMed ID: 22013903 [No Abstract] [Full Text] [Related]
25. [Forty years of biotechnology revolution]. Soutullo D Rev Derecho Genoma Hum; 2014; Spec No():53-84. PubMed ID: 24915694 [No Abstract] [Full Text] [Related]
26. [Mass spectrometry in medicine and biotechnology]. Polunina TA; Kireev MN; Khramchenkova TA; Spitsyn AN; Grigor'eva GV Zh Mikrobiol Epidemiol Immunobiol; 2013; (5):112-9. PubMed ID: 24605666 [TBL] [Abstract][Full Text] [Related]
27. An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser. England P Assay Drug Dev Technol; 2004 Apr; 2(2):115-20. PubMed ID: 15165507 [No Abstract] [Full Text] [Related]
28. Profile: Lisa Drakeman. DeFrancesco L Nat Biotechnol; 2005 Sep; 23(9):1035. PubMed ID: 16151382 [No Abstract] [Full Text] [Related]
29. Personal profile: interview with Michael Rae. Interview by Vicki Glaser. Rae M Rejuvenation Res; 2011 Feb; 14(1):95-7. PubMed ID: 21329454 [No Abstract] [Full Text] [Related]
30. Richard Olney's perspective as physician-scientist and patient. Stone K Ann Neurol; 2011 Sep; 70(3):A8-9. PubMed ID: 21905072 [No Abstract] [Full Text] [Related]
31. Alois Jungbauer: protein bioengineering. Jungbauer A Biotechnol J; 2006 Jan; 1(1):26-7. PubMed ID: 16892219 [No Abstract] [Full Text] [Related]
32. Interview with David Kekich by Vicki Glaser. Kekich D Rejuvenation Res; 2010 Feb; 13(1):123-5. PubMed ID: 20230287 [No Abstract] [Full Text] [Related]
33. Interview with L. Stephen Coles, MD, PhD by Vicki Glaser. Coles LS Rejuvenation Res; 2013 Jun; 16(3):250-3. PubMed ID: 23651414 [No Abstract] [Full Text] [Related]
34. Interview with Inder Verma, PhD. Wilson JM; Verma I Hum Gene Ther Clin Dev; 2016 Mar; 27(1):5-8. PubMed ID: 27003750 [No Abstract] [Full Text] [Related]
35. Interview with Jonathan Weiner. [Interviewed by Vicki Glaser]. Weiner J Rejuvenation Res; 2010 Dec; 13(6):737-40. PubMed ID: 21208064 [No Abstract] [Full Text] [Related]
36. An interview with Peter J. Coassin. Interview by Vicki Glaser. Coassin PJ Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687 [No Abstract] [Full Text] [Related]
37. Personal profile: Alan J. Russell, Ph.D. Interview by Vicki Glaser. Russell AJ Rejuvenation Res; 2012 Feb; 15(1):108-12. PubMed ID: 22352438 [No Abstract] [Full Text] [Related]
38. Matthew Kiernan: bringing hope to patients with ALS. Kirby T Lancet Neurol; 2013 Mar; 12(3):229. PubMed ID: 23415565 [No Abstract] [Full Text] [Related]
39. Baywatch: San Francisco. Smaglik P Nature; 2004 Feb; 427(6975):658-9. PubMed ID: 14961125 [No Abstract] [Full Text] [Related]
40. Telethinking: with Right Honorable Lord Roger Swinfen and Lady Pat Swinfen. Interview by Vicki Glaser. Glaser V Telemed J E Health; 2008 Sep; 14(7):633-6. PubMed ID: 18817490 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]